Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

HIV-1 Vpu interference with innate cell-mediated immune mechanisms.

Sandberg JK, Andersson SK, Bächle SM, Nixon DF, Moll M.

Curr HIV Res. 2012 Jun;10(4):327-33. Review.

2.

Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.

Moll M, Andersson SK, Smed-Sörensen A, Sandberg JK.

Blood. 2010 Sep 16;116(11):1876-84. doi: 10.1182/blood-2009-09-243667. Epub 2010 Jun 8.

3.

Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.

Paquin-Proulx D, Gibbs A, Bächle SM, Checa A, Introini A, Leeansyah E, Wheelock CE, Nixon DF, Broliden K, Tjernlund A, Moll M, Sandberg JK.

J Immunol. 2016 Sep 1;197(5):1843-51. doi: 10.4049/jimmunol.1600556. Epub 2016 Aug 1.

4.

Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.

Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, Planelles V, Barker E.

Cell Host Microbe. 2010 Nov 18;8(5):397-409. doi: 10.1016/j.chom.2010.10.008.

5.

Involvement of a C-terminal motif in the interference of primate lentiviral Vpu proteins with CD1d-mediated antigen presentation.

Bächle SM, Sauter D, Sibitz S, Sandberg JK, Kirchhoff F, Moll M.

Sci Rep. 2015 Apr 15;5:9675. doi: 10.1038/srep09675.

6.

HIV-1 Vpu affects the anterograde transport and the glycosylation pattern of NTB-A.

Bolduan S, Hubel P, Reif T, Lodermeyer V, Höhne K, Fritz JV, Sauter D, Kirchhoff F, Fackler OT, Schindler M, Schubert U.

Virology. 2013 Jun 5;440(2):190-203. doi: 10.1016/j.virol.2013.02.021. Epub 2013 Mar 22.

7.

Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.

Horst D, Geerdink RJ, Gram AM, Stoppelenburg AJ, Ressing ME.

Viruses. 2012 Oct 23;4(10):2379-99. doi: 10.3390/v4102379. Review.

8.

HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.

Alvarez RA, Hamlin RE, Monroe A, Moldt B, Hotta MT, Rodriguez Caprio G, Fierer DS, Simon V, Chen BK.

J Virol. 2014 Jun;88(11):6031-46. doi: 10.1128/JVI.00449-14. Epub 2014 Mar 12.

9.

HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.

Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M.

J Virol. 2015 May;89(10):5687-700. doi: 10.1128/JVI.00611-15. Epub 2015 Mar 11.

10.

Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity.

Arias JF, Heyer LN, von Bredow B, Weisgrau KL, Moldt B, Burton DR, Rakasz EG, Evans DT.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6425-30. doi: 10.1073/pnas.1321507111. Epub 2014 Apr 14.

11.

Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells.

Bego MG, Côté É, Aschman N, Mercier J, Weissenhorn W, Cohen ÉA.

PLoS Pathog. 2015 Jul 14;11(7):e1005024. doi: 10.1371/journal.ppat.1005024. eCollection 2015 Jul.

12.

Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.

Pickering S, Hué S, Kim EY, Reddy S, Wolinsky SM, Neil SJ.

PLoS Pathog. 2014 Jan;10(1):e1003895. doi: 10.1371/journal.ppat.1003895. Epub 2014 Jan 23. Erratum in: PLoS Pathog. 2014 Apr;10(4):e1004118.

13.

Emerging role of the host restriction factor tetherin in viral immune sensing.

Hotter D, Sauter D, Kirchhoff F.

J Mol Biol. 2013 Dec 13;425(24):4956-64. doi: 10.1016/j.jmb.2013.09.029. Epub 2013 Sep 26. Review.

PMID:
24075872
15.

Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles.

Galaski J, Ahmad F, Tibroni N, Pujol FM, Müller B, Schmidt RE, Fackler OT.

J Acquir Immune Defic Syndr. 2016 May 1;72(1):1-10. doi: 10.1097/QAI.0000000000000917.

PMID:
26656785
16.

Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin.

Iwami S, Sato K, Morita S, Inaba H, Kobayashi T, Takeuchi JS, Kimura Y, Misawa N, Ren F, Iwasa Y, Aihara K, Koyanagi Y.

Sci Rep. 2015 Jul 17;5:12256. doi: 10.1038/srep12256.

17.

Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin.

Andrew AJ, Miyagi E, Strebel K.

J Virol. 2011 Mar;85(6):2611-9. doi: 10.1128/JVI.02080-10. Epub 2010 Dec 29.

18.

HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction.

Schmidt S, Fritz JV, Bitzegeio J, Fackler OT, Keppler OT.

MBio. 2011 May 24;2(3):e00036-11. doi: 10.1128/mBio.00036-11. Print 2011.

19.

HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

Madhavi V, Wines BD, Amin J, Emery S; ENCORE1 Study Group, Lopez E, Kelleher A; Sydney LTNP Study Group, Center RJ, Hogarth PM, Chung AW, Kent SJ, Stratov I.

J Virol. 2017 Aug 24;91(18). pii: e00700-17. doi: 10.1128/JVI.00700-17. Print 2017 Sep 15.

PMID:
28701393
20.

Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Lawson V.

Immunology. 2012 Sep;137(1):20-7. doi: 10.1111/j.1365-2567.2012.03612.x. Review.

Supplemental Content

Support Center